Correlation Between Anebulo Pharmaceuticals and Oric Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Oric Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Oric Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Oric Pharmaceuticals, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Oric Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Oric Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Oric Pharmaceuticals.
Diversification Opportunities for Anebulo Pharmaceuticals and Oric Pharmaceuticals
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Anebulo and Oric is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Oric Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oric Pharmaceuticals and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Oric Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oric Pharmaceuticals has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Oric Pharmaceuticals go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Oric Pharmaceuticals
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Oric Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Anebulo Pharmaceuticals is 1.72 times less risky than Oric Pharmaceuticals. The stock trades about -0.01 of its potential returns per unit of risk. The Oric Pharmaceuticals is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 826.00 in Oric Pharmaceuticals on November 3, 2024 and sell it today you would earn a total of 216.00 from holding Oric Pharmaceuticals or generate 26.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. Oric Pharmaceuticals
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| Oric Pharmaceuticals |
Anebulo Pharmaceuticals and Oric Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and Oric Pharmaceuticals
The main advantage of trading using opposite Anebulo Pharmaceuticals and Oric Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Oric Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oric Pharmaceuticals will offset losses from the drop in Oric Pharmaceuticals' long position.| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
| Oric Pharmaceuticals vs. Seer Inc | Oric Pharmaceuticals vs. Anebulo Pharmaceuticals | Oric Pharmaceuticals vs. Cullinan Oncology LLC | Oric Pharmaceuticals vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |